Bacteremia Due to Bacillus clausii (Alkalihalobacillus clausii): An Emerging Concern—Report of Two Cases
DOI:
https://doi.org/10.22516/25007440.1437Keywords:
Bacillus clausii, bacteremia, infectious diarrheal disease, immunocompromised hostAbstract
Background: The impact of probiotics on the control and management of diarrheal disease, both acute and chronic, has been significant in recent years. One example is the frequent use of Bacillus clausii, currently known as Alkalihalobacillus clausii, which is widely administered across diverse populations, from children to older adults. However, an emerging concern has arisen for which high-impact epidemiological data are lacking; few descriptive studies exist, and most reports consist of case reports, such as bacteremia caused by B. clausii. This bacterium exhibits a broad intrinsic resistance profile, complicating eradication and requiring prolonged antimicrobial regimens.
Case summary: This report presents two cases, each with immunosuppressive conditions (invasive lung carcinoma and myelodysplastic neoplasm), who received treatment with B. clausii during medical care. Both developed systemic inflammatory response requiring vasoactive support, mechanical ventilation, and broad-spectrum antibiotics, with B. clausii isolated from peripheral blood cultures and identified by spectrophotometry. Despite treatment, both patients had unfavorable clinical outcomes, ultimately resulting in death.
Conclusion: Mortality in these patients is extremely high, particularly among immunocompromised individuals, underscoring the need for prudent use of probiotics to prevent this complication.
Downloads
References
Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. Documento de consenso de expertos. Declaración de consenso de la Asociación Científica Internacional de Probióticos y Prebióticos sobre el alcance y el uso apropiado del término probiótico. Nat Rev Gastroenterol Hepatol. 2014;11:506-14. https://doi.org/10.1038/nrgastro.2014.66
Elshaghabee FMF, Rokana N, Gulhane RD, Sharma C, Panwar H. Bacillus como posible probiótico: estado actual, preocupaciones y perspectivas futuras. Front Microbiol. 2017;8:1490. https://doi.org/10.3389/fmicb.2017.01490
Cutting SM, Ricca E. Formadores de esporas bacterianas: amigos y enemigos. FEMS Microbiol Lett. 2014;358(2):107-9. https://doi.org/10.1111/1574-6968.12572
Hoyles L, Honda H, Logan NA, Halket G, La Ragione RM, McCartney AL. Reconocimiento de una mayor diversidad de especies de Bacillus y bacterias relacionadas en heces humanas. Res Microbiol. 2012;163(1):3-13. https://doi.org/10.1016/j.resmic.2011.10.004
Celandroni F, Vecchione A, Cara A, Mazzantini D, Lupetti A, Ghelardi E. Identificación de especies de Bacillus: Implicación en la calidad de las formulaciones probióticas. PLoS ONE. 2019;14(5):e0217021. https://doi.org/10.1371/journal.pone.0217021
Acosta-Rodríguez-Bueno CP, Abreu Y Abreu AT, Guarner F, Guno MJV, Pehlivanoğlu E, Perez M 3rd. Bacillus clausii for Gastrointestinal Disorders: A Narrative Literature Review. Adv Ther. 2022;39(11):4854-4874. https://doi.org/10.1007/s12325-022-02285-0
Didari T, Solki S, Mozaffari S, Nikfar S, Abdollahi M. A systematic review of the safety of probiotics. Expert Opin Drug Saf. 2014;13(2):227-239. https://doi.org/10.1517/14740338.2014.872627
Lakshmi SG, Jayanthi N, Saravanan M, Ratna MS. Evaluación de seguridad de Bacillus clausii UBBC07, un probiótico formador de esporas. Toxicol Rep. 2017;4:62-71. https://doi.org/10.1016/j.toxrep.2016.12.004
Sudha MR, Bhonagiri S, Kumar MA. Eficacia de la cepa UBBC-07 de Bacillus clausii en el tratamiento de pacientes que sufren diarrea aguda. Benef Microbes. 2013;4:211-6. https://doi.org/10.3920/BM2012.0034
Corredor-Rengifo D, Tello-Cajiao ME, García-Molina FA, Montero-Riascos LF, Segura-Cheng JD. Bacillus clausii bacteremia following probiotic use: a report of two cases. Cureus. 2024;16(4):e57853. https://doi.org/10.7759/cureus.57853
García JP, Hoyos JA, Alzate JA, Cristancho E. Bacteriemia tras la administración de Bacillus clausii para el tratamiento de la diarrea aguda: reporte de un caso. Biomedica. 2021;41(Supl 2):13-20. https://doi.org/10.7705/biomedica.5662
Dionne JC, Mbuagbaw L, Devlin JW, Duprey MS, Cartin-Ceba R, Tsang J, et al. Diarrhea during critical illness: a multicenter cohort study. Intensive Care Med. 2022;48(5):570-579. https://doi.org/10.1007/s00134-022-06663-8
Agüero A, Infante K. Fallo intestinal en el paciente crítico: reconocimiento, abordaje multidisciplinario unidades dedicadas. Rev Med Urug. 2021;37(2):e37209. https://doi.org/10.29193/RMU.37.2.8
Gargar JD, Divinagracia RM. When good things go bad: a case series of bacteremia from probiotics. Chest. 2019;155(4):92A. https://doi.org/10.1016/j.chest.2019.02.091
Díaz-Madriz JP, Zavaleta-Monestel E, Rojas-Chinchilla C, Arguedas-Chacón S, Serrano-Arias B, Ferreto-Meza MA, et al. Bacteremia Following Alkalihalobacillus clausii (Formerly Bacillus clausii) Administration in Immunosuppressed Adults: A Case Series. Bacteria. 2023;2(4):185-95. https://doi.org/10.3390/bacteria2040014
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Revista colombiana de Gastroenterología

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
Los autores/as ceden sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación en esta revista.
Los contenidos están protegidos bajo una licencia de Creative Commons Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional.

| Article metrics | |
|---|---|
| Abstract views | 724 |
| Galley views | 271 |
| PDF Views | 246 |
| HTML views | 0 |
| Other views | 25 |














